Profile
Frank W.
Falkenberg is a scientific director who founded CyTuVax BV in 2011.
Frank W. Falkenberg active positions
| Companies | Position | Start |
|---|---|---|
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | Founder | 2010-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
CyTuVax BV
CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Frank W. Falkenberg
